Diabetic Retinopathy—Innovation in Diagnosis and Treatment

Dear Colleagues,

Recent discoveries of novel fundamental mechanisms of action, the development of novel diagnostics and therapeutics and the advancement of translational and clinical research focused on molecular mechanisms of action have resulted in impactful innovation for the spectrum of ocular complications resulting from diabetes mellitus. The interplay of research and clinical approaches identifying molecular mechanisms of action to prevent and systemically treat diabetes and to locally target diabetic retinopathy, diabetic macular edema, ocular vascular disease and neovascularization and retinal neurodegeneration, drives significant research efforts in a diverse range of scientific and medical fields, such as neuroscience, pharmaceutical science, protein biochemistry, medicinal chemistry, endocrinology and ophthalmology. These significant advances towards addressing significant unmet clinical needs through the development of novel therapeutics are accompanied by the successful development and implementation of novel diagnostic modalities, both in terms of new medical devices, imaging and sensor technologies, and in terms of software development, most notably the use of artificial intelligence-based systems to identify molecular mechanisms of action. Therefore, this Special Issue invites manuscript submissions, namely, research and review papers, with a focus on basic science and clinical research innovation to determine molecular mechanisms of action in the fields of the diagnosis, prevention and treatment of ocular complications resulting from diabetes and specifically affecting the retina.

Prof. Dr. Peter Koulen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• diabetes mellitus
• diabetic macular edema
• diagnostics
• drug development
• neovascularization
• neurodegeneration
• neuroprotection
• retina
• therapeutics
• vascular disease